Corcoran Chad A, Huang Ying, Sheikh M Saeed
Department of Pharmacology, State University of New York, Upstate Medical University, Syracuse, New York 13210, USA.
Cancer Biol Ther. 2004 Aug;3(8):721-5. doi: 10.4161/cbt.3.8.1068. Epub 2004 Aug 1.
For years, the growth inhibitory effects of the tumor suppressor p53 were thought to be antagonized predominantly by the ubiquitin ligase, MDM2. It has long been established that MDM2 physically associates with p53 and targets this tumor suppressor for proteasomal degradation. In light of recent findings, it now appears that MDM2 may not be the only ubiquitin ligase that negatively controls p53 function. Two recently discovered proteins, Pirh2 and COP1, are also believed to facilitate p53 degradation via the ubiquitin-proteasome pathway. Both proteins are upregulated by p53 as well as genotoxic stress and each has been found to directly promote p53 ubiquitination and degradation. Future studies in this field will now face the challenge of elucidating the physiological significance of three molecules all apparently able to independently facilitate p53 degradation and abrogate its function.
多年来,人们一直认为肿瘤抑制因子p53的生长抑制作用主要受到泛素连接酶MDM2的拮抗。长期以来已经确定,MDM2与p53发生物理结合,并将这种肿瘤抑制因子靶向蛋白酶体降解。鉴于最近的研究发现,现在看来MDM2可能不是唯一对p53功能进行负调控的泛素连接酶。最近发现的两种蛋白质,Pirh2和COP1,也被认为可通过泛素-蛋白酶体途径促进p53的降解。这两种蛋白质都受p53以及基因毒性应激上调,并且已发现它们各自直接促进p53的泛素化和降解。该领域未来的研究将面临阐明这三种显然都能够独立促进p53降解并消除其功能的分子的生理意义这一挑战。